Skip to main content

Advertisement

Articles

Page 34 of 35

  1. Adipose tissue secreted proteins are collectively named adipocytokines and include leptin, adiponectin, resistin, collagenous repeat-containing sequence of 26-kDa protein (CORS-26) and omentin. Several of thes...

    Authors: Sylvia Wurm, Markus Neumeier, Johanna Weigert, Andreas Schäffler and Christa Buechler

    Citation: Cardiovascular Diabetology 2007 6:7

    Content type: Original investigation

    Published on:

  2. Diabetes is associated with a cardiomyopathy that is independent of coronary artery disease or hypertension. In the present study we used in vivo magnetic resonance imaging (MRI) and echocardiographic techniqu...

    Authors: Xichun Yu, Yasvir A Tesiram, Rheal A Towner, Andrew Abbott, Eugene Patterson, Shijun Huang, Marion W Garrett, Suresh Chandrasekaran, Satoshi Matsuzaki, Luke I Szweda, Brian E Gordon and David C Kem

    Citation: Cardiovascular Diabetology 2007 6:6

    Content type: Original investigation

    Published on:

  3. Diabetes mellitus is a growing public health problem, for which efficient and timely surveillance is a key policy. Administrative databases offer relevant opportunities for this purpose. We aim to monitor the ...

    Authors: Stefano Brocco, Cristiana Visentin, Ugo Fedeli, Elena Schievano, Angelo Avogaro, Margherita Andretta, Francesco Avossa and Paolo Spolaore

    Citation: Cardiovascular Diabetology 2007 6:5

    Content type: Original investigation

    Published on:

  4. The rising prevalence of obesity and metabolic syndrome (MetS) has received increased attention since both place individuals at risk for Type II diabetes and cardiovascular disease. Insulin resistance (IR) has...

    Authors: Sarita Dhuper, Hillel W Cohen, Josephine Daniel, Padmasree Gumidyala, Vipin Agarwalla, Rosemarie St Victor and Sunil Dhuper

    Citation: Cardiovascular Diabetology 2007 6:4

    Content type: Original investigation

    Published on:

  5. The omental adipose tissue is pathogenetically involved in both type 2 diabetes mellitus (T2D) and chronic inflammatory bowel diseases (IBD) such as Ulcerative colitis (UC) and Crohn's Disease (CD). Thus, adip...

    Authors: Andreas Schäffler, Martina Zeitoun, Hella Wobser, Christa Buechler, Charalampos Aslanidis and Hans Herfarth

    Citation: Cardiovascular Diabetology 2007 6:3

    Content type: Original investigation

    Published on:

  6. Elevated blood glucose values are a prognostic factor in myocardial infarction (MI) patients. The unfavourable relation between hyperglycemia and outcome is known for admission glucose and fasting glucose afte...

    Authors: Iwan CC van der Horst, Maarten WN Nijsten, Mathijs Vogelzang and Felix Zijlstra

    Citation: Cardiovascular Diabetology 2007 6:2

    Content type: Original investigation

    Published on:

  7. The high glucose levels typically occurring among adults with type 2 diabetes contribute to blood vessel injury and complications such as blindness, kidney failure, heart disease, and stroke. Higher physical a...

    Authors: Kaberi Dasgupta, Cathy Chan, Deborah Da Costa, Louise Pilote, Mirella De Civita, Nancy Ross, Ian Strachan, Ronald Sigal and Lawrence Joseph

    Citation: Cardiovascular Diabetology 2007 6:1

    Content type: Study protocol

    Published on:

  8. Coronary artery disease (CAD) is a major vascular complication of diabetes mellitus and reveals high mortality. Up to 30% of diabetic patients with myocardial ischemia remain asymptomatic and are associated wi...

    Authors: Li Jin Pu, Lin Lu, Xue Wei Xu, Rui Yan Zhang, Qi Zhang, Jian Sheng Zhang, Jian Hu, Zheng Kun Yang, Feng Hua Ding, Qiu Jin Chen, Sheng Lou, Jie Shen, Dan Hong Fang and Wei Feng Shen

    Citation: Cardiovascular Diabetology 2006 5:27

    Content type: Original investigation

    Published on:

  9. In spite of a large amount of studies in anesthetized animals, isolated hearts, and in vitro cardiomyocytes, to our knowledge, myocardial function was never studied in conscious diabetic rats. Myocardial perfo...

    Authors: Giulianna R Borges, Mauro de Oliveira, Helio C Salgado and Rubens Fazan Jr

    Citation: Cardiovascular Diabetology 2006 5:26

    Content type: Original investigation

    Published on:

  10. The metabolic syndrome together with insulin resistance and their consequences are basic factors in pathogenesis of atherosclerosis. Chronic infections with herpes simplex virus type 1 (HSV-1), cytomegalovirus...

    Authors: Iraj Nabipour, Katayon Vahdat, Seyed Mojtaba Jafari, Raha Pazoki and Zahra Sanjdideh

    Citation: Cardiovascular Diabetology 2006 5:25

    Content type: Original investigation

    Published on:

  11. Target organ damage (mainly cardiac and renal damage) is easy to evaluate in outpatient clinics and offers valuable information about patient's cardiovascular risk. The purpose of this study was to evaluate, u...

    Authors: Luis Cea-Calvo, Pedro Conthe, Pablo Gómez-Fernández, Fernando de Alvaro and Cristina Fernández-Pérez

    Citation: Cardiovascular Diabetology 2006 5:23

    Content type: Original investigation

    Published on:

  12. Obstructive sleep apnoea (OSA) is a cardio-metabolic disorder. Whether metabolic syndrome (MS), insulin resistance (IR) and albuminuria are independently associated with OSA is unclear, but defining the intera...

    Authors: A Gruber, F Horwood, J Sithole, NJ Ali and I Idris

    Citation: Cardiovascular Diabetology 2006 5:22

    Content type: Original investigation

    Published on:

  13. Patients with diabetes already fulfill one diagnostic criterion for MS according to the existing classifications. Our aim was to identify one single clinical parameter, which could effectively predict the pres...

    Authors: Maria Kompoti, Anargiros Mariolis, Alevizos Alevizos, Ioannis Kyriazis, Ioannis Protopsaltis, Eleni Dimou, Ioannis Lentzas, Dimitrios Levisianou, Afroditi Gova and Andreas Melidonis

    Citation: Cardiovascular Diabetology 2006 5:21

    Content type: Methodology

    Published on:

  14. Lowering of low-density lipoprotein cholesterol with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) is clearly efficacious in the treatment and prevention of coronary artery disease. Howe...

    Authors: Alexander Tenenbaum, Enrique Z Fisman, Michael Motro and Yehuda Adler

    Citation: Cardiovascular Diabetology 2006 5:20

    Content type: Review

    Published on:

  15. The aim of this study was to determine if hypertensive type 2 diabetic patients, when compared to patients with essential hypertension have an increased left ventricular mass index (LVMI) and a worse diastolic...

    Authors: João S Felício, Juliana T Pacheco, Sandra R Ferreira, Frida Plavnik, Valdir A Moisés, Oswaldo Kohlmann Jr, Artur B Ribeiro and Maria T Zanella

    Citation: Cardiovascular Diabetology 2006 5:19

    Content type: Original investigation

    Published on:

  16. Diabetes mellitus is an important risk factor for increased vein graft failure after bypass surgery. However, the cellular and molecular mechanism(s) underlying vessel attrition in this population remain large...

    Authors: Kevin M Rice, Devashish H Desai, Sunil K Kakarla, Anjaiah Katta, Deborah L Preston, Paulette Wehner and Eric R Blough

    Citation: Cardiovascular Diabetology 2006 5:18

    Content type: Original investigation

    Published on:

  17. Systemic adiponectin is reduced in patients with cardiovascular disease (CVD) and low adiponectin may contribute to the pathogenesis of atherosclerosis. However, circulating adiponectin is elevated in type 1 d...

    Authors: Sabine Abke, Markus Neumeier, Johanna Weigert, Gabriele Wehrwein, Elke Eggenhofer, Andreas Schäffler, Kevin Maier, Charalampos Aslanidis, Jürgen Schölmerich and Christa Buechler

    Citation: Cardiovascular Diabetology 2006 5:17

    Content type: Original investigation

    Published on:

  18. Secondary treatment of arteriosclerosis may be applicable for the primary prevention of atherosclerosis in diabetic patients. This prospective, 2-year follow-up study was designed to determine the efficacy and...

    Authors: Yoshimitsu Yamasaki, Young-Seol Kim and Ryuzo Kawamori

    Citation: Cardiovascular Diabetology 2006 5:16

    Content type: Methodology

    Published on:

  19. Coronary artery disease is the leading cause of death in industrialized countries and most patients with diabetes die from complications of atherosclerosis. The objective of this study was to determine the pre...

    Authors: Alireza Esteghamati, Mehrshad Abbasi, Manouchehr Nakhjavani, Abbas Yousefizadeh, Amelita P Basa and Hamid Afshar

    Citation: Cardiovascular Diabetology 2006 5:15

    Content type: Original investigation

    Published on:

  20. Tumor necrosis factor-α (TNFα) is a mediator of insulin resistance. Plasma levels of soluble TNFα receptors (sTNFR1 and sTNFR2) probably reflect paracrine action of the cytokine. TNFα is also a regulator of li...

    Authors: Marek Straczkowski, Irina Kowalska, Agnieszka Nikolajuk, Agnieszka Adamska, Malgorzata Karolczuk-Zarachowicz, Monika Karczewska-Kupczewska, Agnieszka Kozlowska and Maria Gorska

    Citation: Cardiovascular Diabetology 2006 5:14

    Content type: Original investigation

    Published on:

  21. Foam cell formation in diabetic patients often occurs in the presence of high insulin and glucose levels. To test whether hyperinsulinemic hyperglycemic conditions affect foam cell differentiation, we examined...

    Authors: Pavel N Shashkin, Nitin Jain, Yury I Miller, Benjamin A Rissing, Yuqing Huo, Susanna R Keller, George E Vandenhoff, Jerry L Nadler and Thomas M McIntyre

    Citation: Cardiovascular Diabetology 2006 5:13

    Content type: Original investigation

    Published on:

  22. Adiponectin acts as an antidiabetic, antiinflammatory and antiatherogenic adipokine. These effects are assumed to be mediated by the recently discovered adiponectin receptors AdipoR1 and AdipoR2.

    Authors: Uli C Broedl, Michael Lehrke, Elisabeth Fleischer-Brielmaier, Anne B Tietz, Jutta M Nagel, Burkhard Göke, Peter Lohse and Klaus G Parhofer

    Citation: Cardiovascular Diabetology 2006 5:11

    Content type: Original investigation

    Published on:

  23. South-Asians have lower adiponectin levels compared to Caucasians. It was not clear however, if this intrinsic feature is related to aspects of glucose metabolism. This study aims to determine the relationship...

    Authors: Hanif Wasim, Nasser M Al-Daghri, Raja Chetty, Phillip G McTernan, A H Barnett and Sudhesh Kumar

    Citation: Cardiovascular Diabetology 2006 5:10

    Content type: Original investigation

    Published on:

  24. Impaired glucose tolerance (IGT) is associated with increased cardiovascular risk. The pathophysiological mechanisms linking post-challenge hyperglycemia to accelerated atherosclerosis, however remain to be el...

    Authors: Isabella Schmoelzer and Thomas C Wascher

    Citation: Cardiovascular Diabetology 2006 5:9

    Content type: Original investigation

    Published on:

  25. Anemia and diabetes are risk factors for short-term mortality following an acute myocardial infarction(AMI). Anemia is more prevalent in patients with diabetes. We performed a retrospective study to assess the...

    Authors: David H Shu, Thomas PP Ransom, Colleen M O'Connell, Jafna L Cox, Stephanie M Kaiser, Shirl A Gee, Richard C Rowe, Ehud Ur and Syed Ali Imran

    Citation: Cardiovascular Diabetology 2006 5:8

    Content type: Original investigation

    Published on:

  26. Diabetes is a major risk factor for cardiovascular disease. In particular, type 1 diabetes compromises the cardiac function of individuals at a relatively early age due to the protracted course of abnormal glu...

    Authors: Rajprasad Loganathan, Mehmet Bilgen, Baraa Al-Hafez, Mohammed D Alenezy and Irina V Smirnova

    Citation: Cardiovascular Diabetology 2006 5:7

    Content type: Original investigation

    Published on:

  27. Atherosclerosis is an inflammatory disease in which a perpetuated activation of NFkappaB via the RAGE (receptor for advanced glycation end products)-MAPK signalling pathway may play an important pathogenetic r...

    Authors: Philipp Ehlermann, Kai Eggers, Angelika Bierhaus, Patrick Most, Dieter Weichenhan, Johannes Greten, Peter P Nawroth, Hugo A Katus and Andrew Remppis

    Citation: Cardiovascular Diabetology 2006 5:6

    Content type: Original investigation

    Published on:

  28. Monocytes play an important role in innate immunity and atherosclerosis. A disturbed secretion of cytokines in lipopolysaccharide (LPS) activated monocytes from type 1 diabetes (T1D) patients has been describe...

    Authors: Gabriele Wehrwein, Markus Neumeier, Andreas Schäffler, Andrea Kopp, Johanna Weigert, Sabine Abke, Jürgen Schölmerich and Christa Buechler

    Citation: Cardiovascular Diabetology 2006 5:5

    Content type: Original investigation

    Published on:

  29. The endothelium is a thin monocelular layer that covers all the inner surface of the blood vessels, separating the circulating blood from the tissues. It is not an inactive organ, quite the opposite. It works ...

    Authors: Ricardo J Esper, Roberto A Nordaby, Jorge O Vilariño, Antonio Paragano, José L Cacharrón and Rogelio A Machado

    Citation: Cardiovascular Diabetology 2006 5:4

    Content type: Review

    Published on:

  30. Inflammation contributes to cardiovascular disease and is exacerbated with increased adiposity, particularly omental adiposity; however, the role of epicardial fat is poorly understood.

    Authors: Adam R Baker, Nancy F da Silva, David W Quinn, Alison L Harte, Domenico Pagano, Robert S Bonser, Sudhesh Kumar and Philip G McTernan

    Citation: Cardiovascular Diabetology 2006 5:1

    Content type: Original investigation

    Published on:

  31. To determine the prevalence of, and patient characteristics associated with, antiplatelet therapy in a cohort of primary care patients with Type 1 or Type2 diabetes.

    Authors: Shaun R Miller, Benjamin Littenberg and Charles D MacLean

    Citation: Cardiovascular Diabetology 2005 4:18

    Content type: Original investigation

    Published on:

  32. Individuals with diabetes are twice as likely to develop peripheral arterial disease (PAD), the manifestation of extensive atherosclerosis throughout the lower extremities. One putative determinant of PAD is t...

    Authors: Rebecca L Pollex, Mary Mamakeesick, Bernard Zinman, Stewart B Harris, Anthony JG Hanley and Robert A Hegele

    Citation: Cardiovascular Diabetology 2005 4:17

    Content type: Original investigation

    Published on:

  33. Accelerated atherosclerosis is one of the major vascular complications of diabetes. Factors including hyperglycemia and hyperinsulinemia may contribute to accelerated vascular disease. Among the several mechan...

    Authors: Wenlan Duan, Latha Paka and Sivaram Pillarisetti

    Citation: Cardiovascular Diabetology 2005 4:16

    Content type: Original investigation

    Published on:

  34. The aim of the present study was to evaluate, by heart rate variability (HRV) with 24-hours ECG Holter (HRV), the circadian autonomic activity in offspring of type 2 diabetic subjects and the relation with ins...

    Authors: A Fiorentini, A Perciaccante, A Paris, P Serra and L Tubani

    Citation: Cardiovascular Diabetology 2005 4:15

    Content type: Original investigation

    Published on:

  35. There are three peroxisome proliferator-activated receptors (PPARs) subtypes which are commonly designated PPAR alpha, PPAR gamma and PPAR beta/delta. PPAR alpha activation increases high density lipoprotein (...

    Authors: Alexander Tenenbaum, Michael Motro and Enrique Z Fisman

    Citation: Cardiovascular Diabetology 2005 4:14

    Content type: Review

    Published on:

  36. The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study is examining the effects of long-term fibrate therapy on coronary heart disease (CHD) event rates in patients with diabetes mellitus. T...

    Authors:

    Citation: Cardiovascular Diabetology 2005 4:13

    Content type: Original investigation

    Published on:

  37. Uncontrolled hyperglycemia is the main risk factor in the development of diabetic vascular complications. The endothelial cells are the first cells targeted by hyperglycemia. The mechanism of endothelial injur...

    Authors: Juying Han, Anil K Mandal and Linda M Hiebert

    Citation: Cardiovascular Diabetology 2005 4:12

    Content type: Original investigation

    Published on:

  38. The objective of this study was to determine the rate of blood pressure control according to 4 sets of Canadian guidelines published over a decade in patients with diabetes mellitus attending Diabetes Centres ...

    Authors: Cory Russell, Peggy Dunbar, Sonia Salisbury, Ingrid Sketris and George Kephart

    Citation: Cardiovascular Diabetology 2005 4:11

    Content type: Methodology

    Published on:

  39. Resistin is an adipocyte-derived factor implicated in obesity-associated type 2 diabetes (T2DM). This study examines the association between human serum resistin, T2DM and coronary heart disease.

    Authors: N Al-Daghri, R Chetty, PG McTernan, K Al-Rubean, O Al-Attas, AF Jones and S Kumar

    Citation: Cardiovascular Diabetology 2005 4:10

    Content type: Original investigation

    Published on:

  40. The vascular endothelial basement membrane and extra cellular matrix is a compilation of different macromolecules organized by physical entanglements, opposing ionic charges, chemical covalent bonding, and cro...

    Authors: Melvin R Hayden, James R Sowers and Suresh C Tyagi

    Citation: Cardiovascular Diabetology 2005 4:9

    Content type: Review

    Published on:

  41. Drugs in the same class are generally thought to be therapeutically equivalent because of similar mechanisms of action (the so-called "class effect"). However, statins differ in multiple characteristics, inclu...

    Authors: Enrique Z Fisman, Yehuda Adler and Alexander Tenenbaum

    Citation: Cardiovascular Diabetology 2005 4:8

    Content type: Editorial

    Published on:

  42. The Use of Rosuvastatin versus Atorvastatin iN type 2 diabetes mellitUS (URANUS) study compared rosuvastatin with atorvastatin for the reduction of low-density lipoprotein cholesterol (LDL-C) in patients with ...

    Authors: Christian Berne and Annica Siewert-Delle

    Citation: Cardiovascular Diabetology 2005 4:7

    Content type: Original investigation

    Published on:

  43. Metabolic syndrome is a cluster of common cardiovascular risk factors that includes hypertension and insulin resistance. Hypertension and diabetes mellitus are frequent comorbidities and, like metabolic syndro...

    Authors: Cristiana Vitale, Giuseppe Mercuro, Carlotta Castiglioni, Alessandra Cornoldi, Arianna Tulli, Massimo Fini, Maurizio Volterrani and Giuseppe MC Rosano

    Citation: Cardiovascular Diabetology 2005 4:6

    Content type: Original investigation

    Published on:

  44. Cardiovascular complications, characterized by endothelial dysfunction and accelerated atherosclerosis, are the leading cause of morbidity and mortality associated with diabetes. There is growing evidence that...

    Authors: Jeanette Schultz Johansen, Alex K Harris, David J Rychly and Adviye Ergul

    Citation: Cardiovascular Diabetology 2005 4:5

    Content type: Review

    Published on:

  45. Vascular calcification is associated with metabolic syndrome, diabetes, hypertension, atherosclerosis, chronic kidney disease, and end stage renal disease. Each of the above contributes to an accelerated and p...

    Authors: Melvin R Hayden, Suresh C Tyagi, Lisa Kolb, James R Sowers and Ramesh Khanna

    Citation: Cardiovascular Diabetology 2005 4:4

    Content type: Review

    Published on:

  46. In the present study we tested the hypothesis that progression of streptozotocin (STZ)-induced diabetes (14-days to 28-days) would produce renal and vascular dysfunction that correlate with altered p38- mitoge...

    Authors: Hongmei Chen, Sachin Brahmbhatt, Akanksha Gupta and Avadhesh C Sharma

    Citation: Cardiovascular Diabetology 2005 4:3

    Content type: Original investigation

    Published on:

Annual Journal Metrics

Advertisement